Last updated on May 2019

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects


Brief description of study

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Clinical Study Identifier: NCT03001115

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.